The Ulcerative colitis - ustekinumab as a new biologic therapy, review 2024
Biologic agents have significantly transformed the therapeutic approach to ulcerative colitis. Anti-tumor necrosis factor (TNF) agents were the pioneering biologic drugs introduced to induce and maintain remission in this inflammatory bowel disease. Recently, ustekinumab, another biologic option, ha...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Book |
Published: |
Nicolaus Copernicus University in Toruń,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |